PCM1 was also altered which is associated with papillary thyroid carcinomas and a variety of hematological malignancies, including atypical chronic myeloid leukemia and T-cell lymphoma [32, 33]. This evidence concerns the gene PCM1 and differentiated thyroid carcinoma.